A novel form of light chain gene replacement
轻链基因替换的新形式
基本信息
- 批准号:10330601
- 负责人:
- 金额:$ 18.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-19 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAllelesAntibodiesAntibody FormationAntigen ReceptorsB cell repertoireB-LymphocytesBase SequenceBindingCategoriesCellsChimera organismCodeDNADataDependenceDevelopmentEphrin-A5EpitopesEventExonsExploratory/Developmental GrantFoundationsFramework RegionsFrequenciesGene ConversionGene RearrangementGenerationsGenesGenetic RecombinationGenomic InstabilityHeavy-Chain ImmunoglobulinsHybridomasHybridsImmuneImmunityImmunoglobulin Somatic HypermutationImmunoglobulinsImpairmentIn VitroIndividualKnock-inLeadLecithinLightLiposomesLymphocyteMalignant NeoplasmsMediatingModelingMusMutationNonhomologous DNA End JoiningOrganismPathogenicityPeptide Signal SequencesPopulation HeterogeneityProcessProteinsReceptor GeneRecombinant AntibodyRecurrenceReportingResearchSequence AnalysisSiteStructureSurface AntigensT-LymphocyteTestingTherapeutic antibodiesTransgenic MiceWorkactivation-induced cytidine deaminaseadaptive immunitybasechimeric genedesignevidence basegene replacementgenomic locushigh rewardhigh riskimmunoreactivityinsightkappa-Chain Immunoglobulinsmicrobialmicroorganismnovelprogramsrational designreceptorrepairedsingle cell sequencing
项目摘要
PROJECT SUMMARY
B and T lymphocytes form the foundation of our adaptive immune system, which is based on specific
recognition of foreign molecules by structurally diverse surface antigen receptors. Structural diversity in these
receptors originates through site-specific rearrangement of antigen receptor genes during lymphocyte
development. This rearrangement process, called V(D)J recombination, is initiated when the RAG1/2 proteins
cleave antigen receptor gene segments at recombination signal sequences (RSS) through a nick-hairpin
mechanism, and is completed when the DNA breaks are sensed and repaired by non-homologous end-joining.
Classically, B cell repertoire diversity is considered restricted by the number of functional V, D, and J gene
segments in the immunoglobulin (Ig) heavy and light chain gene loci. However, forms of secondary V(D)J
rearrangement have been reported in which an unrearranged Ig heavy chain V (VH) gene segment replaces a
rearranged VH gene via recombination with a cryptic RSS embedded in the 3’ end of the VH gene (called VH
gene replacement). Mechanistic insight into this process has been hampered by the low frequency of these
events and, typically, the use of germline pre-rearranged VH alleles. Whether similar events occur in the light
chain loci remains unclear. We recently performed bulk light chain repertoire sequencing of B cells from
transgenic mice expressing the Ig VH12 heavy chain, sorted based on immunoreactivity to
phosphatidylcholine. Interestingly, our analysis uncovered infrequent, but recurrent, endogenous hybrid
rearranged Ig kappa V (KV) gene sequences, in which the 3’ end of the highly selected KV4-91 gene was
replaced by another KV gene. Based on this preliminary data, our working hypothesis is that the RAG proteins
mediate KV gene replacement in VH12 mice via cleavage of a cryptic RSS identified in framework region 3 of
the KV gene (KV FR3 cRSS). The proposed project will extend our preliminary findings to confirm KV gene
replacement leads to productive antibody generation in single B cells, test whether the KV FR3 cRSS supports
RAG-mediated cleavage and rearrangement in vitro and in cells, and also exclude activation-induced cytidine
deaminase (AID) as an alternative mechanism for KV gene replacement in VH12 mice. This project will
challenge our current understanding of the theoretical constraints on antibody structural diversity, and lead to
considering KV gene chimeras for rational design of therapeutic antibodies. This work will also highlight an
important potential caveat of automated KV sequence analysis, because such events (regardless of origin)
may be missed in KV gene calls or be mistaken for somatic hypermutation. The potential of this project to shift
existing paradigms places the project in the “high risk-high reward” category for which the R21 was designed.
项目摘要
B和T淋巴细胞形成我们的适应性免疫系统的基础,这是基于特定的
通过结构多样的表面抗原受体识别外来分子。结构多样性在这些
受体起源于淋巴细胞增殖过程中抗原受体基因位点特异性重排
发展这种重排过程称为V(D)J重组,当RAG 1/2蛋白
通过切口发夹在重组信号序列(RSS)处切割抗原受体基因片段
当DNA断裂被感应到并通过非同源末端连接修复时,DNA断裂完成。
传统上,B细胞库多样性被认为受到功能性V、D和J基因数量的限制
免疫球蛋白(IG)重链和轻链基因座中的片段。然而,次级V(D)J的形式
已经报道了重排,其中未重排的IG重链V(VH)基因区段取代了未重排的Ig重链V(VH)基因区段。
通过与嵌在VH基因3'端的隐蔽RSS重组重排的VH基因(称为VH
基因置换)。对这一过程的机械洞察力受到这些低频率的阻碍,
事件,并且通常使用种系预重排的VH等位基因。类似的事件是否发生在
链位点仍不清楚。我们最近进行了大量的轻链库测序的B细胞从
表达IG VH 12重链的转基因小鼠,根据免疫反应性进行分类,
卵磷脂有趣的是,我们的分析揭示了不常见的,但经常性的,内源性杂交,
重排的IG kappa V(KV)基因序列,其中高度选择的KV 4 -91基因的3'末端是
被另一个KV基因取代基于这些初步数据,我们的工作假设是RAG蛋白
在VH 12小鼠中通过切割在VH 12小鼠的框架区3中鉴定的隐蔽RSS介导KV基因置换,
KV基因(KV FR 3 cRSS)。该项目将扩展我们的初步研究结果,以确认KV基因
替换导致单个B细胞中产生生产性抗体,测试KV FR 3 cRSS是否支持
RAG介导的体外和细胞内裂解和重排,也排除激活诱导的胞苷
脱氨酶(AID)作为VH 12小鼠中KV基因置换的替代机制。该项目将
挑战我们目前对抗体结构多样性的理论限制的理解,并导致
考虑KV基因嵌合体用于合理设计治疗性抗体。这项工作还将突出一个
自动KV序列分析的重要潜在警告,因为此类事件(无论起源如何)
可能在KV基因调用中丢失或被误认为体细胞超突变。这个项目的潜力在于
现有的范例将该项目置于“高风险-高回报”类别,而R21正是为此而设计的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick C. Swanson其他文献
Receptor editing constrains development of phosphatidyl choline-specific B cells in VsubH/sub12-transgenic mice
- DOI:
10.1016/j.celrep.2022.110899 - 发表时间:
2022-06-14 - 期刊:
- 影响因子:6.900
- 作者:
Alexandra N. Worth;Victoria L. Palmer;N. Max Schabla;Greg A. Perry;Anna N. Fraser-Philbin;Patrick C. Swanson - 通讯作者:
Patrick C. Swanson
Patrick C. Swanson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick C. Swanson', 18)}}的其他基金
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10430247 - 财政年份:2021
- 资助金额:
$ 18.19万 - 项目类别:
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10302865 - 财政年份:2021
- 资助金额:
$ 18.19万 - 项目类别:
DCAF1(VprBP) regulates FoxO1 to promote Rag transcription
DCAF1(VprBP)调控FoxO1促进Rag转录
- 批准号:
9808408 - 财政年份:2019
- 资助金额:
$ 18.19万 - 项目类别:
Implications of B10-like cell expansion in a model of impaired receptor editing
B10 样细胞扩增对受体编辑受损模型的影响
- 批准号:
9244625 - 财政年份:2016
- 资助金额:
$ 18.19万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8876720 - 财政年份:2012
- 资助金额:
$ 18.19万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8499380 - 财政年份:2012
- 资助金额:
$ 18.19万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8688270 - 财政年份:2012
- 资助金额:
$ 18.19万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8345107 - 财政年份:2012
- 资助金额:
$ 18.19万 - 项目类别:
Defining the role of a novel E3 ubiquitin ligase in V(D)J recombination
定义新型 E3 泛素连接酶在 V(D)J 重组中的作用
- 批准号:
8313160 - 财政年份:2011
- 资助金额:
$ 18.19万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 18.19万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别: